Relmada Therapeutics, Inc. RLMD Payments For Fees
Payments For Fees at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForFees.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s payments for fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s payments for fees?
- Relmada Therapeutics, Inc. (RLMD) reported payments for fees of $3.5M in Q1 2025.
- What does payments for fees mean?
- Cash outflows related to administrative, professional, or regulatory service fees incurred during the ordinary course of business. Monitoring these costs helps assess the efficiency of corporate overhead and external service utilization.